Today: 21 May 2026
Vale stock drops as iron ore rally cools and China policy bets get tested
8 January 2026
1 min read

Vale stock drops as iron ore rally cools and China policy bets get tested

NEW YORK, Jan 8, 2026, 09:45 EST — Regular session

Vale S.A.’s U.S.-listed shares were down about 2.4% at $13.92 in early New York trade on Thursday, after swinging between $13.86 and $14.28 and giving back part of this week’s run-up. The stock closed at $14.26 on Wednesday.

The pullback came as iron ore prices eased after a four-session climb, with traders wary of possible steps by Beijing to cool the market. Benchmark February iron ore on the Singapore Exchange slipped 0.78% to $108.2 a ton, while China’s most-traded May contract was flat at 816 yuan after earlier hitting its highest since July.

Iron ore — Vale’s main profit driver — has been pushing higher this week on signs of steady buying in China ahead of the Lunar New Year, with steel mill utilisation ticking up late last year. On Tuesday, the Dalian contract touched a more-than-five-month high, while the Singapore benchmark traded around $106.55 a ton, a Reuters report showed.

Policy hopes have also been in the mix. China’s central bank said on Tuesday it planned to cut banks’ reserve requirement ratio — the share of deposits lenders must keep in reserve — and interest rates in 2026 to keep liquidity ample.

Investors are also keeping an eye on shareholder payouts. Vale said in a November release that it would pay shareholder remuneration totaling R$3.581771057 per share, with payments to ADR holders — the U.S.-traded receipts for Vale shares — starting on Jan. 14 and March 11, via its depositary.

Beyond daily swings in ore, the next company-specific marker is earnings. Vale has not announced a date, but market calendars estimate the next report around Feb. 18.

Still, iron ore rallies can turn fast if Chinese officials jawbone prices lower or if demand fades, and the market is already watching the longer-run impact of new supply such as Guinea’s Simandou project. A Reuters analysis late last month flagged expectations for iron ore prices to sit just under $100 a ton in 2026, with more supply pressure building later in the decade.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
EV Stocks Mixed in Premarket: Rivian Rises Despite Recall as Tesla, Lucid Slip
Previous Story

EV Stocks Mixed in Premarket: Rivian Rises Despite Recall as Tesla, Lucid Slip

Dow Jones Today: Dow steadies near record highs as jobs report looms and Trump defense talk jolts stocks
Next Story

Dow Jones Today: Dow steadies near record highs as jobs report looms and Trump defense talk jolts stocks

Go toTop